Lonidaminum

Lonidaminum Uses, Dosage, Side Effects, Food Interaction and all others data.

Lonidaminum (LND) is a drug that interferes with energy metabolism of cancer cells, principally inhibiting aerobic glycolytic activity, by its effect on mitochondrially-bound hexokinase (HK). In such way LND could impair energy-requiring processes, as recovery from potentially lethal damage, induced by radiation treatment and by some cytotoxic drugs.

Trade Name Lonidaminum
Generic Lonidamine
Lonidamine Other Names DICA, diclondazolic acid, Doridamina, Lonidamin, lonidamina, Lonidamine, lonidaminum
Type
Formula C15H10Cl2N2O2
Weight Average: 321.158
Monoisotopic: 320.011932988
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Lonidaminum
Lonidaminum

Uses

Investigated for use/treatment in benign prostatic hyperplasia, prostate disorders, and cancer/tumors (unspecified).

How Lonidaminum works

Lonidaminum is an orally administered small molecule that inhibits glycolysis by the inactivation of hexokinase. Hexokinase is an enzyme that catalyzes glucose, the first step in glycolysis. The inhibition of hexokinase by lonidamine is well established. In addition, there is evidence that lonidamine may increase programmed cell death. This stems from the observation that mitochondria and mitochondria-bound hexokinase are crucial for induction of apoptosis; agents that directly effect mitochondria may, therefore, trigger apoptosis. Indeed, in vitro models with lonidamine exhibit the hallmarks of apoptosis, including mitochondrial membrane depolarization, release of cytochrome C, phosphatidylserine externalization, and DNA fragmentation. [PMID: 16986057]

Innovators Monograph

You find simplified version here Lonidaminum

*** Taking medicines without doctor's advice can cause long-term problems.
Share